SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC TO-T/A - Tender offer statement by Third Party: [Amend]
SEC Accession No. 0001193125-23-277516
Filing Date
2023-11-15
Accepted
2023-11-15 06:51:05
Documents
4
Group Members
YOSEMITE FALLS ACQUISITION CORP

Document Format Files

Seq Description Document Type Size
1 SC TO-T/A d426292dsctota.htm SC TO-T/A 21607
2 EX-99.(A)(5)(C) d426292dex99a5c.htm EX-99.(A)(5)(C) 12596
3 GRAPHIC g426292g1115025146517.jpg GRAPHIC 3180
4 GRAPHIC g426292g1115030748695.jpg GRAPHIC 4083
  Complete submission text file 0001193125-23-277516.txt   46323
Mailing Address LILLY CORPORATE CENTER DROP CODE 1094 INDIANAPOLIS IN 46285
Business Address LILLY CORPORATE CTR DROP CODE 1094 INDIANAPOLIS IN 46285 3172762000
ELI LILLY & Co (Filed by) CIK: 0000059478 (see all company filings)

IRS No.: 350470950 | State of Incorp.: IN | Fiscal Year End: 1231
Type: SC TO-T/A
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences

Mailing Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268
Business Address 4850 WEST 78TH STREET INDIANAPOLIS IN 46268 (317) 543-9957
POINT Biopharma Global Inc. (Subject) CIK: 0001811764 (see all company filings)

IRS No.: 850800493 | Fiscal Year End: 1231
Type: SC TO-T/A | Act: 34 | File No.: 005-91575 | Film No.: 231408998
SIC: 2834 Pharmaceutical Preparations
Office of Life Sciences